Vera Therapeutics, Inc. SEC filings VERA

Vera Therapeutics, Inc. has 476 filings in SEC EDGAR's recent list, going back to Feb 25, 2021. Its latest annual report, Form ARS, was filed on Apr 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Vera Therapeutics, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
4 Insider transaction Sep 17, 2026 Sep 15, 2026
8-K Current report
Regulation FD disclosure, Other events
Sep 15, 2026 Sep 15, 2026
4 Insider transaction Sep 14, 2026 Sep 11, 2026
4 Insider transaction Sep 4, 2026 Sep 2, 2026
144 Notice of proposed sale Sep 2, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
4/A Filing Aug 12, 2026 Jul 7, 2026
4/A Filing Aug 12, 2026 Jun 23, 2026
4/A Filing Aug 12, 2026 May 12, 2026
10-Q Quarterly report Aug 10, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 10, 2026 Aug 10, 2026
SCHEDULE 13G Ownership over 5% (passive) Aug 7, 2026 —
4 Insider transaction Aug 5, 2026 Aug 3, 2026
3 Initial insider ownership Aug 5, 2026 Aug 3, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 30, 2026 —
4 Insider transaction Jul 9, 2026 Jul 7, 2026
8-K Current report
Officer or director change
Jul 9, 2026 Jul 9, 2026
8-K Current report
Other events
Jul 7, 2026 Jul 7, 2026
4 Insider transaction Jun 24, 2026 Jun 23, 2026
144 Notice of proposed sale Jun 23, 2026 —
8-K Current report
Other events
Jun 2, 2026 Jun 2, 2026
8-K Current report
Shareholder vote results
May 26, 2026 May 21, 2026
4 Insider transaction May 26, 2026 May 21, 2026
4 Insider transaction May 26, 2026 May 21, 2026
4 Insider transaction May 26, 2026 May 21, 2026
4 Insider transaction May 26, 2026 May 21, 2026
4 Insider transaction May 26, 2026 May 21, 2026
4 Insider transaction May 26, 2026 May 21, 2026
4 Insider transaction May 26, 2026 May 21, 2026
4 Insider transaction May 26, 2026 May 21, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
4 Insider transaction May 13, 2026 May 12, 2026
144 Notice of proposed sale May 12, 2026 —
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
4 Insider transaction Apr 15, 2026 Apr 14, 2026
144 Notice of proposed sale Apr 14, 2026 —
ARS Annual report to shareholders Apr 9, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 9, 2026 —
DEF 14A Proxy statement Apr 9, 2026 May 21, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 1, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
4 Insider transaction Mar 25, 2026 Mar 23, 2026
3 Initial insider ownership Mar 25, 2026 Mar 23, 2026
4 Insider transaction Mar 16, 2026 Mar 13, 2026
SCHEDULE 13G Ownership over 5% (passive) Mar 11, 2026 —
8-K Current report
Officer or director change
Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
3 Initial insider ownership Mar 9, 2026 Mar 5, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 5, 2026 —
S-8 Employee stock plan registration Feb 27, 2026 —
10-K Annual report Feb 26, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 26, 2026 Feb 26, 2026
4 Insider transaction Feb 25, 2026 Feb 23, 2026
4 Insider transaction Feb 25, 2026 Feb 23, 2026
4 Insider transaction Feb 25, 2026 Feb 23, 2026
4 Insider transaction Feb 25, 2026 Feb 23, 2026
4 Insider transaction Feb 25, 2026 Feb 23, 2026
4 Insider transaction Feb 25, 2026 Feb 23, 2026
4 Insider transaction Feb 25, 2026 Feb 23, 2026
144 Notice of proposed sale Feb 23, 2026 —
144 Notice of proposed sale Feb 23, 2026 —
144 Notice of proposed sale Feb 23, 2026 —
144 Notice of proposed sale Feb 23, 2026 —
144 Notice of proposed sale Feb 23, 2026 —
144 Notice of proposed sale Feb 23, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
4 Insider transaction Feb 6, 2026 Feb 4, 2026
4 Insider transaction Feb 6, 2026 Feb 4, 2026
4 Insider transaction Feb 6, 2026 Feb 4, 2026
4 Insider transaction Feb 6, 2026 Feb 4, 2026
4 Insider transaction Feb 6, 2026 Feb 4, 2026
4 Insider transaction Feb 6, 2026 Feb 4, 2026
4 Insider transaction Feb 6, 2026 Feb 4, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 5, 2026 —
3 Initial insider ownership Jan 30, 2026 Jan 20, 2026
SCHEDULE 13G Ownership over 5% (passive) Jan 30, 2026 —
8-K Current report
Officer or director change
Dec 18, 2025 Dec 16, 2025
4 Insider transaction Dec 17, 2025 Dec 15, 2025
4 Insider transaction Dec 15, 2025 Dec 11, 2025
144 Notice of proposed sale Dec 15, 2025 —
8-K Current report
Other events
Dec 10, 2025 Dec 9, 2025
424B5 Prospectus supplement Dec 10, 2025 —
4 Insider transaction Dec 10, 2025 Dec 8, 2025
144 Notice of proposed sale Dec 8, 2025 —
424B5 Prospectus supplement Dec 8, 2025 —
4 Insider transaction Dec 4, 2025 Dec 3, 2025
144 Notice of proposed sale Dec 3, 2025 —
4 Insider transaction Nov 26, 2025 Nov 25, 2025
3 Initial insider ownership Nov 26, 2025 Nov 25, 2025
8-K Current report
Officer or director change
Nov 26, 2025 Nov 25, 2025
4 Insider transaction Nov 25, 2025 Nov 21, 2025
144 Notice of proposed sale Nov 24, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
4 Insider transaction Nov 13, 2025 Nov 11, 2025
8-K Current report
Other events
Nov 6, 2025 Nov 6, 2025
10-Q Quarterly report Nov 5, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 5, 2025 Nov 5, 2025
SCHEDULE 13G Ownership over 5% (passive) Aug 14, 2025 —
8-K Current report
Material agreement, Agreement ended
Aug 5, 2025 Aug 5, 2025
424B5 Prospectus supplement Aug 5, 2025 —
10-Q Quarterly report Aug 5, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 5, 2025 Aug 5, 2025
4 Insider transaction Jun 25, 2025 Jun 23, 2025
SCHEDULE 13G Ownership over 5% (passive) Jun 11, 2025 —
8-K Current report
Material agreement, New debt
Jun 3, 2025 Jun 2, 2025
8-K Current report
Regulation FD disclosure, Other events
Jun 2, 2025 Jun 2, 2025
8-K Current report
Shareholder vote results
May 19, 2025 May 14, 2025
4 Insider transaction May 16, 2025 May 14, 2025
4 Insider transaction May 16, 2025 May 14, 2025
4 Insider transaction May 16, 2025 May 14, 2025
4 Insider transaction May 16, 2025 May 14, 2025
4 Insider transaction May 16, 2025 May 14, 2025
4 Insider transaction May 16, 2025 May 14, 2025
4 Insider transaction May 16, 2025 May 14, 2025
4 Insider transaction May 16, 2025 May 14, 2025
10-Q Quarterly report May 7, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 6, 2025 May 6, 2025
ARS Annual report to shareholders Apr 3, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 3, 2025 —
DEF 14A Proxy statement Apr 3, 2025 May 14, 2025
S-8 Employee stock plan registration Feb 28, 2025 —
10-K Annual report Feb 28, 2025 Dec 31, 2024
4 Insider transaction Feb 27, 2025 Feb 21, 2025
144 Notice of proposed sale Feb 26, 2025 —
8-K Current report
Results of operations
Feb 26, 2025 Feb 26, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
8-K Current report
Regulation FD disclosure
Jan 13, 2025 Jan 13, 2025
4 Insider transaction Jan 10, 2025 Jan 8, 2025
144 Notice of proposed sale Jan 8, 2025 —
4 Insider transaction Dec 20, 2024 Dec 18, 2024
144 Notice of proposed sale Dec 18, 2024 —
4 Insider transaction Dec 13, 2024 Dec 11, 2024
144 Notice of proposed sale Dec 11, 2024 —
4 Insider transaction Nov 27, 2024 Nov 25, 2024
144 Notice of proposed sale Nov 25, 2024 —
4 Insider transaction Nov 20, 2024 Nov 18, 2024
3 Initial insider ownership Nov 20, 2024 Nov 18, 2024
4 Insider transaction Nov 15, 2024 Nov 13, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G Ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G Ownership over 5% (passive) Nov 14, 2024 —
144 Notice of proposed sale Nov 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
SC 13D/A Amended ownership over 5% (active) Nov 4, 2024 —
8-K Current report
Other events
Oct 31, 2024 Oct 29, 2024
424B5 Prospectus supplement Oct 30, 2024 —
4 Insider transaction Oct 30, 2024 Oct 28, 2024
424B5 Prospectus supplement Oct 29, 2024 —
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Oct 28, 2024 Oct 26, 2024
S-3ASR Automatic shelf registration Oct 28, 2024 —
144 Notice of proposed sale Oct 28, 2024 —
4 Insider transaction Oct 25, 2024 Oct 23, 2024
144 Notice of proposed sale Oct 23, 2024 —
4 Insider transaction Oct 11, 2024 Oct 9, 2024
144 Notice of proposed sale Oct 9, 2024 —
8-K Current report
Regulation FD disclosure
Oct 2, 2024 Oct 2, 2024
4 Insider transaction Sep 27, 2024 Sep 25, 2024
144 Notice of proposed sale Sep 25, 2024 —
4 Insider transaction Sep 20, 2024 Sep 18, 2024
144 Notice of proposed sale Sep 18, 2024 —
144 Notice of proposed sale Sep 18, 2024 —
4 Insider transaction Sep 13, 2024 Sep 11, 2024
144 Notice of proposed sale Sep 11, 2024 —
4 Insider transaction Aug 30, 2024 Aug 28, 2024
144 Notice of proposed sale Aug 28, 2024 —
4 Insider transaction Aug 23, 2024 Aug 21, 2024
4 Insider transaction Aug 16, 2024 Aug 14, 2024
144 Notice of proposed sale Aug 14, 2024 —
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
4 Insider transaction Jul 3, 2024 Jul 1, 2024
3 Initial insider ownership Jul 3, 2024 Jul 1, 2024
8-K Current report
Officer or director change
Jul 2, 2024 Jun 26, 2024
8-K Current report
Officer or director change
Jun 12, 2024 Jun 7, 2024
4 Insider transaction Jun 11, 2024 Jun 7, 2024
3 Initial insider ownership Jun 11, 2024 Jun 7, 2024
8-K Current report
Shareholder vote results
May 17, 2024 May 15, 2024
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction May 17, 2024 May 15, 2024
10-Q Quarterly report May 10, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 9, 2024 May 9, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
VERA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Brisbane, CA
SEC filer status
Large accelerated filer
SEC CIK
1831828

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.